Tech Company Financing Transactions
Arrakis Therapeutics Funding Round
Arrakis Therapeutics, operating out of Waltham, secured $75 million from Nextech Invest, venBio and Advent Life Sciences.
Transaction Overview
Nextech Invest (Lead Investor) (Jakob Loven)
venBio (Lead Investor) (Richard Gaster)
Advent Life Sciences (Raj Parekh)
Alexandria Venture Investments
Canaan Partners (Colleen Cuffaro)
Celgene (Russell Petter)
private investors (Henri Termeer)
Osage Partners (Matthew Cohen)
Company Information
Waltham, MA 02451
USA
Management Team
Browse more venture capital transactions:
Prev: 4/19/2019: Phantom AI venture capital transaction
Next: 4/19/2019: Viome venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs